Collaboration to Advance Molecular Imaging Technology
|
By HospiMedica staff writers Posted on 20 Oct 2003 |
|
A collaboration to develop a cost-effective, readily accessible molecular imaging technology that can help more clinics and hospitals diagnose cancer has been announced by Philips Medical Systems (Best, The Netherlands) and CellPoint, L.L.C. (Englewood, CO, USA).
The collaboration will combine Cellpoint's novel diagnostic imaging agent and the nuclear medicine camera of Philips to make functional imaging readily available. The agreement will utilize CellPoint's ethylenedicysteine drug conjugate technology (EC technology), a delivery system that links tissue-specific ligands (hormones, proteins, peptides) or pharmaceutical compounds to radioisotopes for cancer diagnosis and treatment. Using clinical trial data, Philips will further develop and refine imaging techniques for SKYlight, its gantry-free nuclear camera, to determine requirements for the highest possible image quality and quantitative information about patients' disease.
The companies will collaborate on CellPoint's first imaging agent, Tc-99m-EC-deoxyglucose. EC technology allows the deoxyglucose to be labeled with the radioisotope technetium-99m (Tc-99m). The agent will target tumors, while single positron emission computed tomography (SPECT) cameras will image them, including Philips' nuclear medicine cameras. Tumors absorb more glucose than surrounding tissue, so when a cancer patient is injected with this chemically linked agent, active tumors will absorb both the glucose and the radioisotope.
"Philips has outstanding SPECT technology, and we're thrilled to strategically align ourselves with them to help advance molecular imaging agents, enabling more facilities to conduct cancer screening,” said Greg Colip, CEO of CellPoint. The company obtained the worldwide license to EC technology from the University of Texas M.D. Anderson Cancer Center (Houston, USA).
Related Links:
CellPoint
Philips Medical
The collaboration will combine Cellpoint's novel diagnostic imaging agent and the nuclear medicine camera of Philips to make functional imaging readily available. The agreement will utilize CellPoint's ethylenedicysteine drug conjugate technology (EC technology), a delivery system that links tissue-specific ligands (hormones, proteins, peptides) or pharmaceutical compounds to radioisotopes for cancer diagnosis and treatment. Using clinical trial data, Philips will further develop and refine imaging techniques for SKYlight, its gantry-free nuclear camera, to determine requirements for the highest possible image quality and quantitative information about patients' disease.
The companies will collaborate on CellPoint's first imaging agent, Tc-99m-EC-deoxyglucose. EC technology allows the deoxyglucose to be labeled with the radioisotope technetium-99m (Tc-99m). The agent will target tumors, while single positron emission computed tomography (SPECT) cameras will image them, including Philips' nuclear medicine cameras. Tumors absorb more glucose than surrounding tissue, so when a cancer patient is injected with this chemically linked agent, active tumors will absorb both the glucose and the radioisotope.
"Philips has outstanding SPECT technology, and we're thrilled to strategically align ourselves with them to help advance molecular imaging agents, enabling more facilities to conduct cancer screening,” said Greg Colip, CEO of CellPoint. The company obtained the worldwide license to EC technology from the University of Texas M.D. Anderson Cancer Center (Houston, USA).
Related Links:
CellPoint
Philips Medical
Gold Member
Blood Gas Analyzer
i-Check200
X-Ray Generator
Advantage Plus Generators
Medical-Grade Display
HL2316SHTB
Latest Business News
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
- Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
- Endologix Adds FDA-Cleared Peripheral Thrombectomy System
- Artivion Adds FDA-Approved NEXUS System to Aortic Arch Portfolio
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Channels
Artificial Intelligence
view channel
AI Tools Show Potential to Detect Subtle Signs of Interval Breast Cancer
Interval breast cancers, diagnosed after a negative screening mammogram and before the next scheduled exam, remain an important measure of screening performance and are often more aggressive.... Read more
AI Framework Aims to Turn Medical Care from Reactive to Preventive
Health systems face rising burdens from aging populations, chronic disease, and workforce shortages. Medical artificial intelligence (AI) remains concentrated in diagnosis and decision support, leaving... Read more
Critical Care
view channel
Octopus-Inspired Patch Improves Adhesion for Transdermal Drug Delivery
Transdermal drug delivery requires secure contact between a patch and dynamically moving skin. Everyday bending and stretching can open microgaps that degrade adhesion and reduce dose consistency, limiting... Read more
Multimodal AI System Tracks Early Warning Signs of Mental Health Crisis
In the United States, more than 47,000 people die by suicide each year and more than 10 million seriously consider it, according to the U.S. Centers for Disease Control and Prevention. Yet clinicians often... Read more
Surgical Techniques
view channel
New Transvaginal Transducer Improves Imaging for Gynecology and Early Obstetrics
Transvaginal ultrasound is central to gynecology and early obstetrics, where clinicians must balance deep tissue penetration with high-resolution imaging. Switching probes to achieve this balance can interrupt... Read more
Mobile 3-in-1 Imaging System Advances Intraoperative Navigation
Globus Medical’s Excelsius3D intelligent 3-in-1 imaging system has received the CE Mark for commercial sale in the European Union and the United Kingdom. The addition of Excelsius3D expands the company’s... Read more
Patient Care
view channel
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Weighted Blankets Reduce Anxiety in Hospitalized Adults
Anxiety is common among hospitalized adults and can impair recovery, disrupt sleep, and worsen mental health. Although clinicians often use nonpharmacologic strategies, bedside options that act quickly... Read more
Medical Imaging
view channel
AI Imaging Model Predicts Five-Year Breast Cancer Risk from 3D Mammograms
Breast cancer screening programs often struggle to stratify women by near-term risk, which can lead to missed cancers or unnecessary testing. Forecasting who will develop disease within five years is difficult... Read more
Spleen Imaging Signatures May Reveal Hidden Coronary Artery Disease Risk
Coronary artery disease (CAD) remains a leading cause of death despite major gains in managing traditional risk factors. Clinicians still struggle to quantify residual risk and the upstream biology that... Read more
FDA Clears Automated Musculoskeletal Ultrasound Platform for Arthritis Assessment
Musculoskeletal ultrasound is central to evaluating inflammatory arthritis and other joint conditions, but access is limited by workforce shortages and variability in image acquisition. In the United States,... Read more
Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers
Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read moreHealth IT
view channel
Registry-Driven Digital Outreach Boosts Use of Heart Failure Medicines
Heart failure affects more than 64 million people worldwide and is linked to high mortality, reduced quality of life, and heavy healthcare use. Although sodium-glucose cotransporter 2 inhibitors are proven... Read more
Nurse-Coordinated Care Model Improves Heart Failure Outcomes
Heart failure imposes heavy mortality, morbidity, and cost burdens worldwide, yet proven therapies remain underused in routine practice. This inadequate uptake contributes to preventable hospitalizations... Read more
Point of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
